PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Dr. Claudia C. Cotca of C3 Think Tank Appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health
Dr. Claudia C. Cotca of C3 Think Tank appointed as Advisor Chair of Advanced Technology Academic Research Center (ATARC) on Digital AI & Data Analytics Warfighter Health. Together with leadership and military health experts, stakeholders and program officers, Dr. Claudia C Cotca will help support and contribute to the scope and mission of ATARC’s Warfighter Health in incorporating responsibly artificial intelligence in military medicine. - April 13, 2022 - C3 Think Tank
PharmStars Now Accepting Applications for Spring 2022 Accelerator Program; Startups with Digital Innovations in Neurological Disease Are Welcome to Apply
PharmStars, the pharma-focused accelerator for digital health startups, is now accepting applications for its spring 2022 cohort with the theme, “Digital Innovations in Neurological Disease.” - January 04, 2022 - PharmStars
Global Regenerative Academy, independent subsidiary of the Global Regenerative Group Inc., has new board leadership. GRA President is now Prof. Tahsin Beyzadeoglu as announced during the opening Ceremony of GRC Dubai 2021 (November 19-21, 2021) by Mr. Mihail Blagoev (GRG Inc. VP) after being elected by the Scientific Board. - December 21, 2021 - Global Regenerative Academy
12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. - December 08, 2021 - PharmStars
PharmStars, a pharma-focused accelerator for digital health startups, announces the start of its 2021 Showcase Event. At the Showcase Event, the 12 startups in the accelerator’s current cohort will pitch their digital health solutions to PharmStars’ pharma members. The startups and pharma members will also have the opportunity to meet privately to discuss potential partnership opportunities. - November 17, 2021 - PharmStars
PharmStars, the only pharma-focused, member-based accelerator for digital health startups, is pleased to announce that Sumitovant Biopharma has become its newest pharma member, joining existing members including Boehringer Ingelheim, Eli Lilly and Company, and Novo Nordisk. PharmStars focuses on bridging the "pharma-startup gap." PharmStars provides startups with education and mentoring to help them engage with pharma as clients and partners. - November 03, 2021 - PharmStars
OmeCare and Hillsborough City School District Renew Partnership for Student and Faculty COVID-19 PCR Testing
Partnership helps district ensure safety standards and meet COVID-19 testing protocols for the 2021-2022 school year. - October 16, 2021 - OmeCare
The partnership provides a turnkey approach for workplaces, schools, major conventions and other group events looking to ensure safety and meet governmental mandates for students, staff, employees and event participants. - October 01, 2021 - OmeCare
Cayman Chemical Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
The National Institute of Dental and Craniofacial Research has awarded Cayman Chemical with a $1,700,500 grant to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage... - September 19, 2021 - Cayman Chemical Company
Scientists at AbboMax, Inc. Developed the New Panels of Monoclonal Antibodies to Study B- and T-Cell Lymphomas
Lymphoma is a malignant transformation of either B or T cells or their subtypes. All lymphoma subtypes combined are the seventh most common cancer in the United States. The B-cell lymphomas are types of lymphoma affecting B cells. About 85% of lymphomas are of B-cell origin. T-cell lymphomas are lymphomas that affect T cells. AbboMax has developed the new panels of monoclonal antibodies to study B- and T-cell lymphomas. - September 03, 2021 - AbboMax, Inc.
Reverie Psychedelics and Indiana Health Group Partner to Develop World-Class Psychedelic Research Center
Reverie Psychedelics (Reverie), a leading and rapidly growing psychedelic – assisted psychotherapy clinic and research organization, has further expanded its footprint and capabilities by partnering with Indiana Health Group (IHG), the largest provider of psychiatric and mental health and... - August 05, 2021 - Reverie Psychedelics
Foxx Life Sciences celebrates two new manufacturing facilities in Londonderry, New Hampshire and Hyderabad, India. The new locations add four additional SUT (Single Use Technologies) Cleanrooms that will allow Foxx to meet the high demands of their biotechnology and biopharmaceutical customers. New... - August 04, 2021 - Foxx Life Sciences
The 2nd Global Regenerative Medicine Congress will be held in Dubai 9-11 September 2021. Registration is now open. Global Regenerative Academy is a world-renowned medical society scientifically studying the clinical application of biological products in the human body. Regenerative Medicine treatments using biological products have been used to slow down the natural aging process, treat a variety of pathologies and improve the quality of life of patients. - June 28, 2021 - Global Regenerative Academy
2021 Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing and Changes Since 2020 - May 25, 2021 - Life Science Strategy Group, LLC
Cayman Chemical's new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This... - May 16, 2021 - Cayman Chemical Company
As Texas and other parts of the country start to heat up, cooling towers will be in full use. Hyperion Biotechnology offers Legionella testing to monitor for bacteria growth to help reduce the risk of spread from cooling towers. - April 21, 2021 - Hyperion Biotechnology, Inc.
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.
Zifo RnD Solutions has been featuring in this list since 2012 and is the only company in India to have won this award 9 years in a row. - March 15, 2021 - Zifo RnD Solutions
STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.
Hyperion Biotechnology expands Legionella water collection services in several California cities and other U.S. locations. Facility owners can schedule services to support their water safety plans. - February 11, 2021 - Hyperion Biotechnology, Inc.
Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic... - February 10, 2021 - Cayman Chemical Company
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms of epithelial differentiation or for the detection of possible sites of origin of tumors. Primary tumors usually recapitulate the cytokeratin profiles of the cells from which they are derived. They are one of the most effective epithelial differentiation and tumor markers. - January 13, 2021 - AbboMax, Inc.
The Global Regenerative Group and BPB Medica(TM) Italy are very pleased to announce a global consultancy relationship to further develop the distribution of BPB Medica(TM) products. - December 02, 2020 - Global Regenerative Academy
Cayman held a groundbreaking ceremony to start the buildout of a $20 million research and development facility at its headquarters in Ann Arbor, MI. - November 07, 2020 - Cayman Chemical Company
Small business, Evon Medics, LLC today announced that pharmaceutical luminary and cardiologist, Dr. Adeoye Olukotun has joined the advisory board of the company in a formal advisory role. Dr. Olukotun is currently the Chief Executive Officer of CR Strategies, LLC, which consults on clinical trial... - November 01, 2020 - Evon Medics, LLC
After shutdowns due to coronavirus, businesses are reopening and there are steps building owners can take to check the water safety of their buildings. Hyperion provides Legionella water testing to help businesses reduce the risk of Legionella. - November 01, 2020 - Hyperion Biotechnology, Inc.
Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - African Biosciences Inc.
Evon Medics, LLC Has Been Awarded $1.7 Million Grant for the Evaluation of Its Medical Device for the Treatment of Opioid Use Disorder
Small business, Evon Medics, LLC today announced that it has been awarded a non-dilutive grant of $1.7 million for its Phase II SBIR (Small Business Innovation Research) clinical trials for the development and evaluation of its non-invasive Chemosensory-Based Orbitofrontal Cortex Training (CBOT)... - October 11, 2020 - Evon Medics, LLC
The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. - October 10, 2020 - Cayman Chemical Company
Hyperion Offers Testing to Identify If Legionella Bacteria Are Growing in a Building’s Water System. - October 03, 2020 - Hyperion Biotechnology, Inc.
Hyperion Biotechnology is offering complimentary Legionella water testing to local schools in San Antonio, Texas. - September 17, 2020 - Hyperion Biotechnology, Inc.
Digital DNAtix Ltd., the Israeli startup, announced today the grant of US patent No. US10673847B2 titled, “Systems and methods for user authentication based on a genetic sequence.” The patent is part of the company disruptive and innovative proprietary technology incorporating... - September 11, 2020 - Digital DNAtix Ltd.
Zifo RnD Solutions will be the Data Management Service provider for Aurigene Discovery Technologies’ large data driven Phase III oncology trial. - September 06, 2020 - Zifo RnD Solutions
Survey Quantifies eClinical Platform Use and Satisfaction and Identifies Dramatic Perceptual Changes - August 26, 2020 - Life Science Strategy Group, LLC
Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020, for awards to be distributed by November 2, 2020. Grants range from $2,000 - $5,000 and may be awarded as individual or group grants. - August 19, 2020 - Cayman Chemical Company
Legionella Water Testing Kits can help Businesses Reopen Safely. Hyperion Biotechnology now provides everything building owners need to collect samples for laboratory analysis to determine if Legionella bacteria are present. - August 15, 2020 - Hyperion Biotechnology, Inc.
Cayman and GenScript have come together to create a complete package of neoantigen discovery services. Through combined efforts, MHC-associated peptides are identified and verified as immunogenic to guide peptide synthesis for vaccine development. “Cayman provides a complete workflow enabling... - August 15, 2020 - Cayman Chemical Company
Hotel owners can test water systems to ensure guests’ safety from exposure to Legionella, a bacteria that can cause Legionnaires’ disease when spread through mist from a hotel’s water system. - August 07, 2020 - Hyperion Biotechnology, Inc.
Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.
Coronavirus is not the only concern for business owners as they reopen. Another threat to health safety is water-borne bacteria called Legionella. - July 17, 2020 - Hyperion Biotechnology, Inc.
EUPROTEIN Inc., the expert in mammalian expressed protein, has launched the full set of their top-quality recombinant proteins to help researchers around the world for their studies towards this global pandemic. These protein are expressed in human mammalian cells, which inherently is of superior quality compared to those expressed from E. Coli. - July 09, 2020 - EUPROTEIN Inc.
Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. A record high of forty women will benefit from Cayman’s Women in Research program this year. - July 01, 2020 - Cayman Chemical Company
Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals. - June 01, 2020 - Zeteo Biomedical LLC
Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.
Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd
Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC
Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing - April 30, 2020 - Life Science Strategy Group, LLC